Is Singular Genomics Systems Inc (OMIC) a Smart Choice in Medical Instruments & Supplies Wednesday?

A rating of 82 puts Singular Genomics Systems Inc (OMIC) near the top of the Medical Instruments & Supplies industry according to InvestorsObserver. Singular Genomics Systems Inc's score of 82 means it scores higher than 82% of stocks in the industry. Singular Genomics Systems Inc also received an overall rating of 60, putting it above 60% of all stocks. Medical Instruments & Supplies is ranked 91 out of the 148 industries.

OMIC has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on OMIC!

See Full OMIC Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 60 would rank higher than 60 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Singular Genomics Systems Inc Stock Today?

Singular Genomics Systems Inc (OMIC) stock has risen 5.81% while the S&P 500 has fallen -0.2% as of 1:18 PM on Wednesday, Nov 8. OMIC has gained $0.03 from the previous closing price of $0.53 on volume of 4,342,153 shares. Over the past year the S&P 500 is higher by 14.15% while OMIC has fallen -73.46%. OMIC lost -$1.31 per share the over the last 12 months. Click Here to get the full Stock Report for Singular Genomics Systems Inc stock.